Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com
StockNews.com lowered shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) from a hold rating to a sell rating in a report published on Monday. Atara Biotherapeutics Stock Performance NASDAQ:ATRA opened at $0.60 on Monday. The stock has a 50-day simple moving average of $0.74 and a two-hundred day simple moving average of $0.94. Atara Biotherapeutics […]
More Stories
Pioneer Bancorp Announces Successful Annual Meeting Results
Pioneer Bancorp, Inc. (NASDAQ: PBFS) recently held its Annual Meeting of Stockholders on November 19, 2024. During the meeting, several...
Watsco (NYSE:WSO.B) Reaches New 1-Year High – Here’s Why
Watsco Inc (NYSE:WSO.B – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The...
Keysight Technologies (NYSE:KEYS) Releases Q1 2025 Earnings Guidance
Keysight Technologies (NYSE:KEYS – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning....
Eagle Capital Growth Fund, Inc. Declares — Dividend of $0.68 (NYSEAMERICAN:GRF)
Eagle Capital Growth Fund, Inc. (NYSEAMERICAN:GRF – Get Free Report) declared a — dividend on Monday, November 18th,Wall Street Journal...
Weekly Analysts’ Ratings Updates for Yum! Brands (YUM)
Yum! Brands (NYSE: YUM) recently received a number of ratings updates from brokerages and research firms: 11/11/2024 – Yum! Brands...
Atlanticus (NASDAQ:ATLC) Reaches New 12-Month High – Time to Buy?
Atlanticus Holdings Co. (NASDAQ:ATLC – Get Free Report)’s share price reached a new 52-week high on Tuesday . The company...